跳至主要内容
临床试验/CTRI/2020/02/023433
CTRI/2020/02/023433已完成2 期

A comparative clinical evaluation of Siravedha and Agnikarma in the management of Gridhrasi(Sciatica)

Institute for post graduate teaching and research in Ayurveda1 个研究点 分布在 1 个国家目标入组 30 人开始时间: 2020年2月22日最近更新:

试验速览

阶段
2 期
状态
已完成
发起方
入组人数
30
试验地点
1
主要终点
Relief in signs and symptoms of Gridhrasi

研究概览

简要总结

This researchstarted with theaim and objectiveto find the individual and comparative effect of both therapies i.e.Agnikarma and Siravedha. In this study total 30 patients registered werenon-randomly divided in two groups.15 patients in group A and 15 patients in Group B were registered. All 15patients in group A and 15 Patients in Group B completed the treatment and follow up.

In Group A, Agnikarma was done with Panchdhatu**Shalaka at Antrakandra Gulpha Sthana (Lumbo Sacral Spine as well as Ankle region). Total four sitting of procedure Agnikarma were done with a gap of 7 days interval.

In Group B, Siravedha was done at  4 Angulas above or below Janu Sandhiby scalpel vein set. Totaltwo sittingof procedureSiravedha were done with a gap of 15 days interval.

Patients were observedfor relief insign and symptoms like radiating pain, Stambha, Suptata, Spandana, Gaurava etc.at weekly intervalup to 4 weeks. The follow up was done up to one month after treatment in both groups.

Finally study concluded that bothpara-surgical modalities have definite role in treating sciatica but Agnikarmahas shown betterresult incomparison of Siravedha in the management of Gridhrasi (Sciatica).

研究设计

研究类型
Interventional
分配方式
Computer generated randomization
盲法
Open Label

入排标准

年龄范围
30.00 Year(s) 至 70.00 Year(s)(—)
性别
All

入选标准

  • Diagnosed case of Sciatica Patients of Sciatica having SLR 30-70 degree Positive Lasegue sign.

排除标准

  • Age less then 30 and more than 70 years Uncontrolled diabetes mellitus and Hypertension Uncontrolled TB of spine & hip joint Malignancy Avascular necrosis Pregnancy Anaemia Heart disease Fracture related to spine Pitta dominant prakriti patients.

结局指标

主要结局

Relief in signs and symptoms of Gridhrasi

时间窗: 1 month from the day of the enrollment of patient

次要结局

  • Improves quality of life of person(After 2 months from the day of enrollment of patient)

研究者

发起方
Institute for post graduate teaching and research in Ayurveda
申办方类型
Research institution and hospital

研究点 (1)

Loading locations...

相似试验